Search research articles
Contact Us
Filters
Showing results (71-80 of 127) with videos related to
Page
of 13
Sort By:
Cancers
|
September 10, 2020
Spatial Distribution of Focal Lesions in Whole-Body MRI and Influence of MRI Protocol on Staging in Patients with Smoldering Multiple Myeloma According to the New SLiM-CRAB-Criteria
Markus Wennmann, Thomas Hielscher, Laurent Kintzelé, et al.
Haematologica
|
March 22, 2015
A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma
Elias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Hemasphere
|
March 19, 2024
Quantifying <i>NPM1</i> MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?
Sebastian Schwind, Lara Bischof, Marius Bill, et al.
Blood Advances
|
April 7, 2023
Teclistamab impairs detection of BCMA CAR-T cells
Bettina Glatte, Kerstin Wenk, Anja Grahnert, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 31, 2024
Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma
Janine Kirchberg, Luise Fischer, Patrick Born, et al.
Cancers
|
December 10, 2021
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry
Maximilian Merz, Hartmut Goldschmidt, Parameswaran Hari, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2023
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy
Thomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, et al.
Blood Advances
|
October 18, 2018
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma
Tilmann Bochtler, Maximilian Merz, Thomas Hielscher, et al.
Haematologica
|
May 13, 2017
Longitudinal fluorescence <i>in situ</i> hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
Maximilian Merz, Anna Jauch, Thomas Hielscher, et al.
Transplantation and Cellular Therapy
|
May 17, 2026
Impact of Renal Impairment and Lymphodepletion Regimen on Outcomes after CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Nora Grieb, Thomas Wiemers, Patrick Born, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 127) with videos related to
Sort By:
Page
of 13
Cancers
|
September 10, 2020
Spatial Distribution of Focal Lesions in Whole-Body MRI and Influence of MRI Protocol on Staging in Patients with Smoldering Multiple Myeloma According to the New SLiM-CRAB-Criteria
Markus Wennmann, Thomas Hielscher, Laurent Kintzelé, et al.
Haematologica
|
March 22, 2015
A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma
Elias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Hemasphere
|
March 19, 2024
Quantifying <i>NPM1</i> MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?
Sebastian Schwind, Lara Bischof, Marius Bill, et al.
Blood Advances
|
April 7, 2023
Teclistamab impairs detection of BCMA CAR-T cells
Bettina Glatte, Kerstin Wenk, Anja Grahnert, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 31, 2024
Impact of Previous Allogeneic Hematopoietic Stem Cell Transplantation on Chimeric Antigen Receptor (CAR) T Cell Treatment for Relapsed/Refractory Multiple Myeloma
Janine Kirchberg, Luise Fischer, Patrick Born, et al.
Cancers
|
December 10, 2021
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry
Maximilian Merz, Hartmut Goldschmidt, Parameswaran Hari, et al.
Journal of Cancer Research and Clinical Oncology
|
January 20, 2023
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy
Thomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, et al.
Blood Advances
|
October 18, 2018
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma
Tilmann Bochtler, Maximilian Merz, Thomas Hielscher, et al.
Haematologica
|
May 13, 2017
Longitudinal fluorescence <i>in situ</i> hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
Maximilian Merz, Anna Jauch, Thomas Hielscher, et al.
Transplantation and Cellular Therapy
|
May 17, 2026
Impact of Renal Impairment and Lymphodepletion Regimen on Outcomes after CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Nora Grieb, Thomas Wiemers, Patrick Born, et al.
Page
of 13